Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, posing a major challenge to health systems. There are a variety of ... GLP-1 receptor agonists such as semaglutide are changing the way type 2 diabetes and obesity are treated.

Understanding the Context

But these drugs have also shown a surprising ability to improve cardiovascular health — and ... Immune system overreactions may be the true culprit of cardiac illness—and lifesaving drugs can calm them down ... Becker's Hospital Review: Cardiovascular drugs associated with more errors than other drug classes Researchers found cardiovascular drugs were associated with 24.7 percent of all medication errors, followed by antibiotics at 19.1 percent, electrolytes at 11.3 percent, endocrine drugs at 8.8 percent ... Fox News: Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds Cardiovascular diseases are the number one cause of death globally.

Key Insights

They include conditions such as coronary heart disease (CHD), heart attack, high blood pressure, arrhythmias, congenital heart ...